+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biobank Market Size, Share & Trends Analysis Report by Product (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobank Type (Real, Virtual), Service, Application, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 4661536
Description Jump to:
The global biobanks market size is expected to reach USD 136.91 billion by 2030, registering a CAGR of 8.8% during the forecast period. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The ‘BioResource’ was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia-Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights

  • The biobanking equipment segment accounted for the maximum revenue share in 2023 owing to the high cost of instruments coupled with an increase in the number of biorepositories
  • The biobanking and repository services segment accounted for the largest revenue share in 2023 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
  • Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
  • The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
  • The therapeutics application segment accounted for the largest revenue share in 2023 owing to the growing popularity of cell therapies for cancer treatment
  • Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Service
1.2.3. Biospecimen Type
1.2.4. Biobanks Type
1.2.5. Application
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia-Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Service outlook
2.2.3. Biospecimen type outlook
2.2.4. Biobanks type outlook
2.2.5. Application outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Biobanks Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
3.2.1.2. Increased focus on precision medicine and genetic testing
3.2.1.3. Changes in biobanking operations
3.2.1.4. Increase in the number of clinical trials globally
3.2.1.5. Growing industry and research collaborations
3.2.1.6. Technology advancement and automation
3.2.2. Market restraint analysis
3.2.2.1. Disruptions in supply chain management due to COVID-19
3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.3. Sustainability challenges for biobanks
3.2.2.4. Other challenges in biobanking specimens for research
3.3. Biobanks Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Biobanks Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Biobanks Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Biobanks Market: Service Estimates & Trend Analysis
5.1. Service Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Biobanks Market by Service Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Biobanking & repository
5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Lab processing
5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Qualification/ Validation
5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Cold Chain Logistics
5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.5. Other Services
5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Biobanks Market: Biospecimen Type Estimates & Trend Analysis
6.1. Biospecimen Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Biobanks Market by Biospecimen Type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Human Tissues
6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.2. Human Organs
6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3. Stem Cells
6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3.2. Adult Stem Cells
6.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3.3. Embryonic Stem Cells
6.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3.4. IPS Cells
6.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3.5. Other Stem Cells
6.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.4. Other biospecimens
6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Biobanks Market: Biobanks Type Estimates & Trend Analysis
7.1. Biobanks Type Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Biobanks Market by Biobanks Type Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Physical/Real biobanks
7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.1.2. Tissue Biobanks
7.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.1.3. Population based biobanks
7.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.1.4. Genetic (DNA/RNA)
7.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.1.5. Disease based biobanks
7.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Virtual biobanks
7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Biobanks Market: Application Estimates & Trend Analysis
8.1. Application Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Biobanks Market by Application Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Therapeutics
8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.4.2. Drug discovery & clinical research
8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.4.3. Clinical Diagnostics
8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
8.4.4. Other Applications
8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Biobanks Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
9.7. Asia-Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework/reimbursement structure
9.8.3.3. Competitive scenario
9.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Thermo Fisher Scientific Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Merck KGaA
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Qiagen
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Hamilton Company
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Tecan Trading AG
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Danaher Corporation
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Becton, Dickinson, and Company (BD)
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Biocision, LLC.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Taylor-Wharton
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Charles River Laboratories
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Lonza
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Stemcell Technologies
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Biovault Family
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Promocell Gmbh
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Precision Cellular Storage Ltd. (Virgin Health Bank)
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America biobanks market, by region, 2018-2030 (USD Million)
Table 3 North America biobanks market, by product, 2018-2030 (USD Million)
Table 4 North America biobanks market, by service, 2018-2030 (USD Million)
Table 5 North America biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 6 North America biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 7 North America biobanks market, by application, 2018-2030 (USD Million)
Table 8 U.S. biobanks market, by product, 2018-2030 (USD Million)
Table 9 U.S. biobanks market, by service, 2018-2030 (USD Million)
Table 10 U.S. biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 11 U.S. biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 12 U.S. biobanks market, by application, 2018-2030 (USD Million)
Table 13 Canada biobanks market, by product, 2018-2030 (USD Million)
Table 14 Canada biobanks market, by service, 2018-2030 (USD Million)
Table 15 Canada biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 16 Canada biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 17 Canada biobanks market, by application, 2018-2030 (USD Million)
Table 18 Europe biobanks market, by region, 2018-2030 (USD Million)
Table 19 Europe biobanks market, by product, 2018-2030 (USD Million)
Table 20 Europe biobanks market, by service, 2018-2030 (USD Million)
Table 21 Europe biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 22 Europe biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 23 Europe biobanks market, by application, 2018-2030 (USD Million)
Table 24 Germany biobanks market, by product, 2018-2030 (USD Million)
Table 25 Germany biobanks market, by service, 2018-2030 (USD Million)
Table 26 Germany biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 27 Germany biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 28 Germany biobanks market, by application, 2018-2030 (USD Million)
Table 29 UK biobanks market, by product, 2018-2030 (USD Million)
Table 30 UK biobanks market, by service, 2018-2030 (USD Million)
Table 31 UK biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 32 UK biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 33 UK biobanks market, by application, 2018-2030 (USD Million)
Table 34 France biobanks market, by product, 2018-2030 (USD Million)
Table 35 France biobanks market, by service, 2018-2030 (USD Million)
Table 36 France biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 37 France biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 38 France biobanks market, by application, 2018-2030 (USD Million)
Table 39 Italy biobanks market, by product, 2018-2030 (USD Million)
Table 40 Italy biobanks market, by service, 2018-2030 (USD Million)
Table 41 Italy biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 42 Italy biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 43 Italy biobanks market, by application, 2018-2030 (USD Million)
Table 44 Spain biobanks market, by product, 2018-2030 (USD Million)
Table 45 Spain biobanks market, by service, 2018-2030 (USD Million)
Table 46 Spain biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 47 Spain biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 48 Spain biobanks market, by application, 2018-2030 (USD Million)
Table 49 Denmark biobanks market, by product, 2018-2030 (USD Million)
Table 50 Denmark biobanks market, by service, 2018-2030 (USD Million)
Table 51 Denmark biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 52 Denmark biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 53 Denmark biobanks market, by application, 2018-2030 (USD Million)
Table 54 Sweden biobanks market, by product, 2018-2030 (USD Million)
Table 55 Sweden biobanks market, by service, 2018-2030 (USD Million)
Table 56 Sweden biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 57 Sweden biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 58 Sweden biobanks market, by application, 2018-2030 (USD Million)
Table 59 Norway biobanks market, by product, 2018-2030 (USD Million)
Table 60 Norway biobanks market, by service, 2018-2030 (USD Million)
Table 61 Norway biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 62 Norway biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 63 Norway biobanks market, by application, 2018-2030 (USD Million)
Table 64 Asia-Pacific biobanks market, by region, 2018-2030 (USD Million)
Table 65 Asia-Pacific biobanks market, by product, 2018-2030 (USD Million)
Table 66 Asia-Pacific biobanks market, by service, 2018-2030 (USD Million)
Table 67 Asia-Pacific biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 68 Asia-Pacific biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 69 Asia-Pacific biobanks market, by application, 2018-2030 (USD Million)
Table 70 China biobanks market, by product, 2018-2030 (USD Million)
Table 71 China biobanks market, by service, 2018-2030 (USD Million)
Table 72 China biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 73 China biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 74 China biobanks market, by application, 2018-2030 (USD Million)
Table 75 Japan biobanks market, by product, 2018-2030 (USD Million)
Table 76 Japan biobanks market, by service, 2018-2030 (USD Million)
Table 77 Japan biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 78 Japan biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 79 Japan biobanks market, by application, 2018-2030 (USD Million)
Table 80 India biobanks market, by product, 2018-2030 (USD Million)
Table 81 India biobanks market, by service, 2018-2030 (USD Million)
Table 82 India biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 83 India biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 84 India biobanks market, by application, 2018-2030 (USD Million)
Table 85 South Korea biobanks market, by product, 2018-2030 (USD Million)
Table 86 South Korea biobanks market, by service, 2018-2030 (USD Million)
Table 87 South Korea biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 88 South Korea biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 89 South Korea biobanks market, by application, 2018-2030 (USD Million)
Table 90 Australia biobanks market, by product, 2018-2030 (USD Million)
Table 91 Australia biobanks market, by service, 2018-2030 (USD Million)
Table 92 Australia biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 93 Australia biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 94 Australia biobanks market, by application, 2018-2030 (USD Million)
Table 95 Thailand biobanks market, by product, 2018-2030 (USD Million)
Table 96 Thailand biobanks market, by service, 2018-2030 (USD Million)
Table 97 Thailand biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 98 Thailand biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 99 Thailand biobanks market, by application, 2018-2030 (USD Million)
Table 100 Latin America biobanks market, by product, 2018-2030 (USD Million)
Table 101 Latin America biobanks market, by service, 2018-2030 (USD Million)
Table 102 Latin America biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 103 Latin America biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 104 Latin America biobanks market, by application, 2018-2030 (USD Million)
Table 105 Brazil biobanks market, by product, 2018-2030 (USD Million)
Table 106 Brazil biobanks market, by service, 2018-2030 (USD Million)
Table 107 Brazil biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 108 Brazil biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 109 Brazil biobanks market, by application, 2018-2030 (USD Million)
Table 110 Mexico biobanks market, by product, 2018-2030 (USD Million)
Table 111 Mexico biobanks market, by service, 2018-2030 (USD Million)
Table 112 Mexico biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 113 Mexico biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 114 Mexico biobanks market, by application, 2018-2030 (USD Million)
Table 115 Argentina biobanks market, by product, 2018-2030 (USD Million)
Table 116 Argentina biobanks market, by service, 2018-2030 (USD Million)
Table 117 Argentina biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 118 Argentina biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 119 Argentina biobanks market, by application, 2018-2030 (USD Million)
Table 120 MEA biobanks market, by region, 2018-2030 (USD Million)
Table 121 MEA biobanks market, by product, 2018-2030 (USD Million)
Table 122 MEA biobanks market, by service, 2018-2030 (USD Million)
Table 123 MEA biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 124 MEA biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 125 MEA biobanks market, by application, 2018-2030 (USD Million)
Table 126 South Africa biobanks market, by product, 2018-2030 (USD Million)
Table 127 South Africa biobanks market, by service, 2018-2030 (USD Million)
Table 128 South Africa biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 129 South Africa biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 130 South Africa biobanks market, by application, 2018-2030 (USD Million)
Table 131 Saudi Arabia biobanks market, by product, 2018-2030 (USD Million)
Table 132 Saudi Arabia biobanks market, by service, 2018-2030 (USD Million)
Table 133 Saudi Arabia biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 134 Saudi Arabia biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 135 Saudi Arabia biobanks market, by application, 2018-2030 (USD Million)
Table 136 UAE biobanks market, by product, 2018-2030 (USD Million)
Table 137 UAE biobanks market, by service, 2018-2030 (USD Million)
Table 138 UAE biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 139 UAE biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 140 UAE biobanks market, by application, 2018-2030 (USD Million)
Table 141 Kuwait biobanks market, by product, 2018-2030 (USD Million)
Table 142 Kuwait biobanks market, by service, 2018-2030 (USD Million)
Table 143 Kuwait biobanks market, by biospecimen type, 2018-2030 (USD Million)
Table 144 Kuwait biobanks market, by biobanks type, 2018-2030 (USD Million)
Table 145 Kuwait biobanks market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Biobanks market: market outlook
Figure 14 Biobanks competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Biobanks market driver impact
Figure 20 Biobanks market restraint impact
Figure 21 Biobanks market strategic initiatives analysis
Figure 22 Biobanks market: Product movement analysis
Figure 23 Biobanks market: Product outlook and key takeaways
Figure 24 Biobanking equipment market estimates and forecast, 2018-2030
Figure 25 Temperature control systems estimates and forecast, 2018-2030
Figure 26 Freezers & refrigerators market estimates and forecast, 2018-2030
Figure 27 Cryogenic storage systems market estimates and forecast, 2018-2030
Figure 28 Thawing equipment market estimates and forecast, 2018-2030
Figure 29 Incubators & centrifuges market estimates and forecast, 2018-2030
Figure 30 Alarms & monitoring systems market estimates and forecast, 2018-2030
Figure 31 Accessories & other equipment market estimates and forecast, 2018-2030
Figure 32 Biobanking consumables market estimates and forecast, 2018-2030
Figure 33 Laboratory information management systems market estimates and forecast, 2018-2030
Figure 34 Biobanks Market: Service movement Analysis
Figure 35 Biobanks market: Service outlook and key takeaways
Figure 36 Biobanking & repository market estimates and forecasts, 2018-2030
Figure 37 Lab processing market estimates and forecasts,2018-2030
Figure 38 Qualification/ Validation market estimates and forecasts,2018-2030
Figure 39 Cold chain logistics market estimates and forecasts, 2018-2030
Figure 40 Other services market estimates and forecasts,2018-2030
Figure 41 Biobanks market: Biospecimen type movement analysis
Figure 42 Biobanks market: Biospecimen type outlook and key takeaways
Figure 43 Human tissues market estimates and forecasts, 2018-2030
Figure 44 Human organs market estimates and forecasts,2018-2030
Figure 45 Stem cells market estimates and forecasts, 2018-2030
Figure 46 Adult stem cells market estimates and forecasts,2018-2030
Figure 47 Embryonic stem cells market estimates and forecasts, 2018-2030
Figure 48 IPS cells market estimates and forecasts, 2018-2030
Figure 49 Other stem cells market estimates and forecasts, 2018-2030
Figure 50 Other biospecimen market estimates and forecasts, 2018-2030
Figure 51 Biobanks market: Biobanks type movement analysis
Figure 52 Biobanks market: Biobanks type outlook and key takeaways
Figure 53 Physical/Real biobanks market estimates and forecasts, 2018-2030
Figure 54 Tissue biobanks market estimates and forecasts,2018-2030
Figure 55 Population based biobanks market estimates and forecasts, 2018-2030
Figure 56 Genetic (DNA/RNA) market estimates and forecasts,2018-2030
Figure 57 Disease based biobanks market estimates and forecasts, 2018-2030
Figure 58 Virtual biobanks market estimates and forecasts, 2018-2030
Figure 59 Biobanks market: Application movement analysis
Figure 60 Biobanks market: Application outlook and key takeaways
Figure 61 Therapeutics market estimates and forecasts, 2018-2030
Figure 62 Drug discovery & clinical research market estimates and forecasts,2018-2030
Figure 63 Clinical diagnostics market estimates and forecasts, 2018-2030
Figure 64 Other applications market estimates and forecasts,2018-2030
Figure 65 Global biobanks market: Regional movement analysis
Figure 66 Global biobanks market: Regional outlook and key takeaways
Figure 67 Global biobanks market share and leading players
Figure 68 North America market share and leading players
Figure 69 Europe market share and leading players
Figure 70 Asia-Pacific market share and leading players
Figure 71 Latin America market share and leading players
Figure 72 Middle East & Africa market share and leading players
Figure 73 North America: SWOT
Figure 74 Europe SWOT
Figure 75 Asia-Pacific SWOT
Figure 76 Latin America SWOT
Figure 77 MEA SWOT
Figure 78 North America, by country
Figure 79 North America
Figure 80 North America market estimates and forecasts, 2018-2030
Figure 81 U.S.
Figure 82 U.S. market estimates and forecasts, 2018-2030
Figure 83 Canada
Figure 84 Canada market estimates and forecasts, 2018-2030
Figure 85 Europe
Figure 86 Europe market estimates and forecasts, 2018-2030
Figure 87 UK
Figure 88 UK market estimates and forecasts, 2018-2030
Figure 89 Germany
Figure 90 Germany market estimates and forecasts, 2018-2030
Figure 91 France
Figure 92 France market estimates and forecasts, 2018-2030
Figure 93 Italy
Figure 94 Italy market estimates and forecasts, 2018-2030
Figure 95 Spain
Figure 96 Spain market estimates and forecasts, 2018-2030
Figure 97 Denmark
Figure 98 Denmark market estimates and forecasts, 2018-2030
Figure 99 Sweden
Figure 100 Sweden market estimates and forecasts, 2018-2030
Figure 101 Norway
Figure 102 Norway market estimates and forecasts, 2018-2030
Figure 103 Asia-Pacific
Figure 104 Asia-Pacific market estimates and forecasts, 2018-2030
Figure 105 China
Figure 106 China market estimates and forecasts, 2018-2030
Figure 107 Japan
Figure 108 Japan market estimates and forecasts, 2018-2030
Figure 109 India
Figure 110 India market estimates and forecasts, 2018-2030
Figure 111 Thailand
Figure 112 Thailand market estimates and forecasts, 2018-2030
Figure 113 South Korea
Figure 114 South Korea market estimates and forecasts, 2018-2030
Figure 115 Australia
Figure 116 Australia market estimates and forecasts, 2018-2030
Figure 117 Latin America
Figure 118 Latin America market estimates and forecasts, 2018-2030
Figure 119 Brazil
Figure 120 Brazil market estimates and forecasts, 2018-2030
Figure 121 Mexico
Figure 122 Mexico market estimates and forecasts, 2018-2030
Figure 123 Argentina
Figure 124 Argentina market estimates and forecasts, 2018-2030
Figure 125 Middle East and Africa
Figure 126 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 127 South Africa
Figure 128 South Africa market estimates and forecasts, 2018-2030
Figure 129 Saudi Arabia
Figure 130 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 131 UAE
Figure 132 UAE market estimates and forecasts, 2018-2030
Figure 133 Kuwait
Figure 134 Kuwait market estimates and forecasts, 2018-2030
Figure 135 Market share of key market players- Biobanks market

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen
  • Hamilton Company
  • Tecan Trading AG
  • Danaher Corporation
  • Becton, Dickinson, and Company (BD)
  • Biocision, LLC.
  • Taylor-Wharton
  • Charles River Laboratories
  • Lonza
  • Stemcell Technologies
  • Biovault Family
  • Promocell Gmbh
  • Precision Cellular Storage Ltd. (Virgin Health Bank)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 76.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 136.91 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Biobanking Market Overview, 2024-2029 - Product Image

Biobanking Market Overview, 2024-2029

  • Report
  • 128 Pages
  • Global
From
Biobanks Market by Component, Sample Type, Application - Global Forecast 2025-2030 - Product Image

Biobanks Market by Component, Sample Type, Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Biobanking Market Outlook, 2029 - Product Image

Biobanking Market Outlook, 2029

  • Report
  • 257 Pages
  • Global
From
Biobanks Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Biobanks Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Biobanks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Biobanks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.